Invasive carcinoma differs from carcinoma in situ by:March 2005
**Core Concept**
Invasive carcinoma and carcinoma in situ (CIS) are two distinct forms of cancer, differing in their invasion and potential for metastasis. Carcinoma in situ is a non-invasive, pre-cancerous lesion that has not invaded the basement membrane, whereas invasive carcinoma has breached the basement membrane and can metastasize to distant sites.
**Why the Correct Answer is Right**
Invasive carcinoma is characterized by its ability to invade surrounding tissues and potentially metastasize. This is due to the loss of cell adhesion molecules, such as E-cadherin, and the acquisition of a mesenchymal phenotype, allowing cancer cells to migrate and invade new tissues. In contrast, CIS is a non-invasive lesion that is confined to the epithelial layer and has not yet acquired the ability to invade or metastasize.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the key difference between invasive carcinoma and CIS. While it is true that CIS is a pre-cancerous lesion, this option does not address the critical distinction between invasive and non-invasive cancer.
**Option B:** This option is incorrect because it is too vague and does not specifically address the key difference between invasive carcinoma and CIS. While cell proliferation is an important aspect of cancer biology, it is not the primary distinction between these two forms of cancer.
**Option C:** This option is incorrect because it is not directly related to the key difference between invasive carcinoma and CIS. While tumor size can be an important prognostic factor, it is not the primary distinction between these two forms of cancer.
**Clinical Pearl / High-Yield Fact**
A key clinical distinction between invasive carcinoma and CIS is that invasive carcinoma is typically associated with a higher risk of metastasis and a worse prognosis. This highlights the importance of accurate histopathological diagnosis in determining the optimal treatment strategy for patients with cancer.
**Correct Answer:** D.